A COVID-19 T-Cell Response Detection Method Based on a Newly Identified Human CD8 + T Cell Epitope from SARS-CoV-2 - Hubei Province, China, 2021.
Zhang, J., Lu, D., Li, M., Liu, M., Yao, S., Zhan, J., Liu, W.J., Gao, G.F.(2022) China CDC Wkly 4: 83-87
- PubMed: 35186375 
- DOI: https://doi.org/10.46234/ccdcw2021.258
- Primary Citation of Related Structures:  
7WKJ - PubMed Abstract: 
Similar to antibody detection, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-specific T-cell response evaluation is also pivotal among the coronavirus disease 2019 (COVID-19) convalescents and the vaccinated populations. Nucleocapsid (N) protein is one of the main structural proteins of SARS-CoV-2 and can trigger T-cell responses in humans.
Organizational Affiliation: 
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.